These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9475910)
1. The sensibility of safety: reflections on the Krever inquiry's final report. Hoey J CMAJ; 1998 Jan; 158(1):59-60. PubMed ID: 9475910 [No Abstract] [Full Text] [Related]
2. Long before Krever's report, blood scare had changed face of medicine. Gray C CMAJ; 1998 Jan; 158(1):89-91. PubMed ID: 9475918 [TBL] [Abstract][Full Text] [Related]
3. There's more to Krever's report than the blood issue--much more. Capen K CMAJ; 1998 Jan; 158(1):92-4. PubMed ID: 9475919 [TBL] [Abstract][Full Text] [Related]
4. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure. Steinberg D J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064 [No Abstract] [Full Text] [Related]
5. Variant Creutzfeldt-Jakob disease and prions in the blood supply. Rohwer RG; Drohan W Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166 [No Abstract] [Full Text] [Related]
6. Comment: dilemmas of dementia. Dodd RY J Clin Ethics; 2001; 12(2):141-2. PubMed ID: 11642065 [No Abstract] [Full Text] [Related]
7. Blood groups differ on donor deferral. Mitka M JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807 [No Abstract] [Full Text] [Related]
8. Current and emerging infectious risks of blood transfusions. Busch MP; Kleinman SH; Nemo GJ JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733 [No Abstract] [Full Text] [Related]
9. The impact on British blood services on BSE and v-CJD: implications for patients, donors and public health. Franklin IM Scott Med J; 1999 Apr; 44(2):35-6. PubMed ID: 10370977 [No Abstract] [Full Text] [Related]
10. A bloody mess. New safeguards will cut supplies of a lifesaving resource. Sobel RK US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392 [No Abstract] [Full Text] [Related]
11. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion. Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617 [No Abstract] [Full Text] [Related]
12. FDA wants more restrictions on donated blood. Mitka M JAMA; 2001 Jul; 286(4):408. PubMed ID: 11466114 [No Abstract] [Full Text] [Related]
18. The reporting of theoretical health risks by the media: Canadian newspaper reporting of potential blood transmission of Creutzfeldt-Jakob disease. Wilson K; Code C; Dornan C; Ahmad N; Hébert P; Graham I BMC Public Health; 2004 Jan; 4():1. PubMed ID: 14706119 [TBL] [Abstract][Full Text] [Related]
19. International views on universal leucodepletion: the perspective in NBS, England. Wallington T Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150 [No Abstract] [Full Text] [Related]
20. Blood & politics. Titus K CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264 [No Abstract] [Full Text] [Related] [Next] [New Search]